Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-31 @ 5:14 AM
Study NCT ID:
NCT07303660
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-26
First Post:
2025-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients
Sponsor:
Lomond Therapeutics Holdings, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-05
First Submit QC Date:
None
Study First Post Date:
2025-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-26
Last Update Post Date Type:
ACTUAL